Northwestern Mutual Wealth Management
MRTX

Northwestern Mutual Wealth Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-80
Closed -$4.7K – 3885
2023
Q4 		$4.7K Hold
80
– – ﹤0.01% 2875
2023
Q3 		$3.48K Hold
80
– – ﹤0.01% 2839
2023
Q2 		$2.89K Hold
80
– – ﹤0.01% 2913
2023
Q1 		$2.97K Hold
80
– – ﹤0.01% 2869
2022
Q4 		$3.63K Hold
80
– – ﹤0.01% 2813
2022
Q3 		$6K Hold
80
– – ﹤0.01% 2660
2022
Q2 		$5K Hold
80
– – ﹤0.01% 2738
2022
Q1 		$7K Hold
80
– – ﹤0.01% 2655
2021
Q4 		$12K Sell
80
-3
-4% -$466 ﹤0.01% 2515
2021
Q3 		$15K Buy
+83
New +$13.4K ﹤0.01% 2338
2015
Q1 		– Sell
-400
Closed -$7K – 1872
2014
Q4 		$7K Buy
+400
New +$6.74K ﹤0.01% 1208

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Northwestern Mutual Wealth Management's MRTX Position: Q1 2024 in Review

Northwestern Mutual Wealth Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 80 shares — an estimated $4.7K sold.

Northwestern Mutual Wealth Management first reported a position in MRTX in Q4 2014 and held it in 11 quarters. The position peaked at $15K in Q3 2021. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Northwestern Mutual Wealth Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 80 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $4.7K.
  • Northwestern Mutual Wealth Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2014 and held it in 11 quarters.
  • Northwestern Mutual Wealth Management's Mirati Therapeutics, Inc. Common Stock position peaked at $15K in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2024, filed 15 May 2024.